Please provide your email address to receive an email when new articles are posted on . Keratoconus is a personal area of interest. In this commentary, I will share a few of my current thoughts on the ...
Please provide your email address to receive an email when new articles are posted on . A 54-year-old man was referred in late 2014 for a consultation for corneal transplant surgery in the left eye.
(NAPSI)—There could be good news if you or someone you care about is ever among the one in 6,000 Americans the National Institutes of Health estimates will be diagnosed with keratoconus (KC). There is ...
On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for ...
BURLINGTON, Mass.--(BUSINESS WIRE)--Epion Therapeutics (Epion) announced the commencement of its Phase 3 Apricity trials for EpiSmart™, the company’s minimally-invasive keratoconus therapy. This marks ...
For most of his young life, the 15-year-old Wyoming High School sophomore ran into things, struggled with activities he enjoyed like catching a baseball and even found himself missing the other hand ...
While keratoconus typically develops in both eyes, it can be asymmetrical, which means it can be much worse in one eye. It’s typically treated with eyeglasses or special contact lenses. Share on ...
SHREVEPORT, La. -- Cross linking is is an eye treatment only offered in this area at the Willis Knighton Eye Institute, and it's performed as a community service. Cross linking is for patients with an ...
The average per-person inflation-adjusted lifetime cost of keratoconus treatment in 2019 was nearly $29,000, with a cumulative economic burden of $3.8 billion, a large retrospective cohort study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results